Daiwa Securities Group Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$2
-33.3%
900.0%0.00%
Q2 2023$3
-96.9%
90
-97.8%
0.00%
-100.0%
Q1 2023$98
+75.0%
4,109
+23.8%
0.00%
Q4 2022$56
-99.9%
3,320
-31.7%
0.00%
-100.0%
Q3 2022$72,000
-22.6%
4,860
-17.7%
0.00%0.0%
Q2 2022$93,000
-1.1%
5,904
+68.5%
0.00%0.0%
Q1 2022$94,000
+4.4%
3,503
+44.0%
0.00%0.0%
Q4 2021$90,000
-10.9%
2,432
+15.3%
0.00%0.0%
Q3 2021$101,000
+4950.0%
2,110
+4487.0%
0.00%
Q2 2021$2,0000.0%460.0%0.00%
Q1 2021$2,0000.0%460.0%0.00%
Q4 2020$2,000460.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders